 |
市场调查报告书
商品编码
1392012
诊断放射性同位素市场：以放射性同位素、依应用、以影像方式、依疾病指示、依最终使用者、按地区Diagnostic Radioisotopes Market, By Radioisotope, By Application, By Imaging Modality, By Disease Indication, By End User, By Geography |
||||||
价格
简介目录
全球诊断放射性同位素市场规模预计将从 2023 年的 56.7 亿美元增至 2030 年的 103.6 亿美元，预测期内复合年增长率为 9%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2022年 | 2023年市场规模 | 56.7亿美元 |
| 实绩资料 | 2018-2021 | 预测期 | 2023-2030 |
| 预测期复合年增长率 | 9.00% | 2030年市场规模预测 | 103.6亿美元 |
图 1. 2023 年诊断放射性同位素的全球市场占有率（按地区划分）
由于慢性病的增加、医学影像技术的进步以及对准确诊断程序的需求不断增长，全球诊断放射性同位素市场正在经历显着增长。诊断放射性同位素是用于医学影像诊断各种疾病和病症的放射性物质。这些放射性同位素发出辐射，可以透过诊断影像设备检测到，使医疗保健专业人员能够可视化和分析身体的内部结构。
市场动态：
全球诊断放射性同位素市场受到多种因素的影响。癌症、心血管疾病和神经系统疾病等慢性疾病的增加增加了对诊断放射性同位素的需求。这些放射性同位素用于各种成像技术，例如正子断层扫描 (PET)、单光子发射电脑断层扫描 (SPECT) 和伽马摄影机，以检测和诊断这些疾病。
然而，也存在阻碍市场成长的因素。诊断放射性同位素的高成本及其生产和使用的严格监管要求对市场成长构成了挑战。放射性同位素的可得性有限以及某些同位素的半衰期短可能限制其在某些诊断程序中的使用。
儘管存在这些挑战，市场上仍存在一些成长机会。 PET/CT 和 SPECT/CT 等混合成像技术的日益普及预计将推动对诊断放射性同位素的需求。此外，新型放射性同位素和放射性药物的开拓以及成像技术的进步预计将出现新的市场机会。
例如，2023年3月16日，製药公司Telix Pharmaceuticals Limited.向美国食品药物管理局（FDA）提交了Illuccix（套件）的补充新药认证（sNDA） 。177 PSMA定向治疗现在可用于选择符合 PSMA 定向治疗资格的转移性前列腺癌患者。
本研究的主要特点
- 该报告对全球诊断放射性同位素市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030年）的市场规模和年复合成长率（CAGR%）。
- 它还揭示了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
- 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
- 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球诊断放射性同位素市场的主要企业。
- 该报告的见解将使行销人员和经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略负责人资讯的决策。
- 全球诊断放射性同位素市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
- 相关人员可以透过用于分析全球诊断放射性同位素市场的各种策略矩阵来促进他们的决策。
目录
第一章 研究目的与假设
- 研究目标
- 假设
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规及趋势分析
- 市场动态
- 促进因素
- 癌症、心血管疾病和神经系统疾病等慢性病盛行率增加
- 抑制因素
- 诊断放射性同位素的成本高昂
- 机会
- 更多采用混合成像技术
- 影响分析
- 主要亮点
- 监管场景
- 产品发布/核准
- PEST分析
- 波特的分析
- 併购场景
第四章全球诊断放射性同位素市场 - 冠状冠状病毒(COVID-19) 大流行的影响
- 新型冠状病毒感染疾病（COVID-19）的流行病学
- 供需面分析
- 经济影响
第 5 章 全球诊断放射性同位素市场（以放射性同位素划分），2023-2030 年
- 锝-99m
- 铊201
- 镓67
- 碘123
- FDG
- 铷82
- 其他的
第六章 全球诊断放射性同位素市场（依应用），2023-2030 年
- 诊断用途
- 治疗用途
第 7 章 全球诊断放射性同位素市场，依影像方式，2023-2030 年
- SPECT
- PET
- β发送器
第 8 章 全球诊断放射性同位素市场，依适应症划分，2023-2030 年
- 肿瘤学
- 心臟病学
- 神经病学
- 甲状腺
- 整形外科
- 内分泌学
- 其他的
第 9 章 全球诊断放射性同位素市场，依最终使用者划分，2023-2030 年
- 医院
- 专科诊所
- 诊断中心
- 学术研究所
- 其他的
第10章全球诊断放射性同位素市场，依地区，2023-2030
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 南非
- 北非
- 中部非洲
第十一章竞争形势
- GE Healthcare
- Siemens Healthineers
- Koninklijke Philips NV
- Cardinal Health
- Lantheus Holdings, Inc.
- Bayer AG
- Bracco
- Eckert & Ziegler
- Nordion（Canada）Inc.
- NTP Radioisotopes
- Curium
- Jubilant Life Sciences Ltd
- IRE
- Isotopia Molecular Imaging Ltd.
- Mallinckrodt Nuclear Medicine LLC
- Jubilant DraxImage Inc.
- Sumitomo Heavy Industries, Ltd.
- Telix Pharmaceuticals Limited
第12章 章节
- 调查方法
- 关于出版商
简介目录
Product Code: CMI6190
Global diagnostic radioisotopes market size is expected to reach US$ 10.36 Bn by 2030, from US$ 5.67 Bn in 2023, at a CAGR of 9% during the forecast period
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 5.67 Bn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 9.00% | 2030 Value Projection: | US$ 10.36 Bn |
Figure 1. Global Diagnostic Radioisotopes Market Share (%), By Region, 2023
Global diagnostic radioisotopes market is witnessing significant growth due to increasing prevalence of chronic diseases, advancements in medical imaging technology, and rising demand for accurate diagnostic procedures. Diagnostic radioisotopes are radioactive substances that are used in medical imaging to diagnose various diseases and conditions. These isotopes emit radiation that can be detected by imaging devices, allowing healthcare professionals to visualize and analyze the internal structures of the body.
Market Dynamics:
Global diagnostic radioisotopes market are influenced by several factors. Increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders boosts demand for diagnostic radioisotopes. These isotopes are used in various imaging techniques such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and gamma cameras to detect and diagnose these diseases.
However, there are certain restraints that may hinder the growth of the market. The high cost of diagnostic radioisotopes and the stringent regulatory requirements for their production and use pose challenges for market growth. The limited availability of radioisotopes and the short half-life of some isotopes may limit their use in certain diagnostic procedures.
Despite these challenges, the market presents several opportunities for growth. Increasing adoption of hybrid imaging techniques, such as PET/CT and SPECT/CT, is expected to boost demand for diagnostic radioisotopes. Moreover, the development of novel radioisotopes and radiopharmaceuticals, as well as advancements in imaging technology, are expected to create new opportunities in the market.
For instance, on March 16, 2023, Telix Pharmaceuticals Limited., a pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved a supplementary New Drug Application (sNDA) for Illuccix (kit for the preparation of gallium Ga 68 gozetotide injection) to enable its use for the selection of patients with metastatic prostate cancer, for whom 177Lu 177 PSMA-directed therapy is indicated.
Key features of the study:
- This report provides in-depth analysis of the global diagnostic radioisotopes market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global diagnostic radioisotopes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Cardinal Health, Lantheus Holdings, Inc., Bayer AG, Bracco, Eckert & Ziegler, Nordion (Canada) Inc., NTP Radioisotopes, Curium, Jubilant Life Sciences Ltd, IRE, Isotopia Molecular Imaging Ltd., Mallinckrodt Nuclear Medicine LLC, Jubilant DraxImage Inc., Sumitomo Heavy Industries, Ltd., and Telix Pharmaceuticals Limited
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global diagnostic radioisotopes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic radioisotopes market
Detailed Segmentation:
- By Radioisotope
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- FDG
- Rubidium-82
- Others
- By Application
- Diagnostic Application
- Therapeutic Application
- By Imaging Modality
-
- SPECT
- PET
- Beta Emitters
- By End User
- Hospitals
- Specialty Clinics
- Diagnostic Centers
- Academic & Research Institutes
- Others
- By Indication
- Oncology
- Cardiology
- Neurology
- Thyroid
- Orthopedic
- Endocrinology
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Top companies in Global Diagnostic Radioisotopes Market
- GE Healthcare
- Siemens Healthineers
- Koninklijke Philips N.V.
- Cardinal Health
- Lantheus Holdings, Inc.
- Bayer AG
- Bracco
- Eckert & Ziegler
- Nordion (Canada) Inc.
- NTP Radioisotopes
- Curium
- Jubilant Life Sciences Ltd
- IRE
- Isotopia Molecular Imaging Ltd.
- Mallinckrodt Nuclear Medicine LLC
- Jubilant DraxImage Inc.
- Sumitomo Heavy Industries, Ltd.
- Telix Pharmaceuticals Limited
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Diagnostic Radioisotopes, By Radioisotope
- Market Diagnostic Radioisotopes, By Application
- Market Diagnostic Radioisotopes, By Imaging Modality
- Market Diagnostic Radioisotopes, By Indication
- Market Diagnostic Radioisotopes, By End User
- Market Diagnostic Radioisotopes, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders
- Restraints
- High cost of diagnostic radioisotopes
- Opportunities
- Increasing adoption of hybrid imaging techniques
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Diagnostic Radioisotopes Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Diagnostic Radioisotopes Market, By Radioisotope, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Technetium-99m
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Thallium-201
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Gallium-67
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Iodine-123
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- FDG
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Rubidium-82
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
6. Global Diagnostic Radioisotopes Market, By Application, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
- Diagnostic Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Therapeutic Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
7. Global Diagnostic Radioisotopes Market, By Imaging Modality, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
- SPECT
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- PET
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Beta Emitters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
8. Global Diagnostic Radioisotopes Market, By Indication, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Thyroid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Orthopedic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
9. Global Diagnostic Radioisotopes Market, By End User, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
10. Global Diagnostic Radioisotopes Market, By Region, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,( US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Koninklijke Philips N.V.
- Cardinal Health
- Lantheus Holdings, Inc.
- Bayer AG
- Bracco
- Eckert & Ziegler
- Nordion (Canada) Inc.
- NTP Radioisotopes
- Curium
- Jubilant Life Sciences Ltd
- IRE
- Isotopia Molecular Imaging Ltd.
- Mallinckrodt Nuclear Medicine LLC
- Jubilant DraxImage Inc.
- Sumitomo Heavy Industries, Ltd.
- Telix Pharmaceuticals Limited
- Analyst Views
12. Section
- Research Methodology
- About us
